Clinical Evidence and Studies on Emsella

Emsella (HIFEM technology) has been evaluated in multiple clinical studies for the treatment of urinary incontinence and pelvic floor strengthening.

Key findings from published research

Clinical studies have reported:

Most protocols studied involve six sessions delivered over several weeks.

Important context

This page summarizes the overall direction of the available clinical evidence. Individual outcomes depend on many factors, including the cause of symptoms and consistency with the recommended treatment protocol.

A consultation is the best way to determine whether the available evidence supports Emsella as an appropriate option in a specific case.

Where to read primary research

Peer-reviewed studies and registered trials on HIFEM technology and pelvic floor treatment can be searched directly through public government and academic databases.

Common questions

Is Emsella backed by clinical studies?

Emsella and HIFEM technology have been evaluated in multiple clinical studies for urinary incontinence and pelvic floor strengthening. Studies have reported symptom improvement, reduced pad use, and gains in muscle strength.

What do Emsella studies show?

Published research has reported improvement in urinary incontinence symptoms after a series of treatments, reduction in absorbent pad use, gains in pelvic floor muscle strength and coordination, and improved quality-of-life measures.

How many sessions were used in the studies?

Most protocols studied involve six sessions delivered over several weeks, which matches the standard treatment protocol used in practice.

Considering Emsella?

A consultation is the best way to determine whether Emsella is appropriate for your situation. Mid Florida Endocrine, led by Victor Matthews, MD, is located in Winter Garden, Florida.